about
Dengue fever and international travelIn vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracilEffect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver TransplantationImpact of swine influenza and quarantine measures on patients and households during the H1N1/09 pandemic.Comparison of immunoglobulin G subclass concentrations in severe community-acquired pneumonia and severe pandemic 2009 influenza A (H1N1) infection.Diagnosing swine flu: the inaccuracy of case definitions during the 2009 pandemic, an attempt at refinement, and the implications for future planning.Primary muscle hydatidosis of the thigh: management of a complicated case with combination adjunctive albendazole and praziquantel chemotherapy.Exploiting information inherent in binding sites of virus-specific antibodies: design of an HCV vaccine candidate cross-reactive with multiple genotypes.Red herring in returned traveler: drug reaction with eosinophilia and systemic symptom (DRESS) syndrome mimicking sepsis.Increasing rates and clinical consequences of nalidixic acid-resistant isolates causing enteric fever in returned travellers: an 18-year experience.Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization?A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individualsProgress in the development of preventive and therapeutic vaccines for hepatitis C virus.Hepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responsesCellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus.Respiratory tract infections in travelers: a review of the GeoSentinel surveillance network.Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis.Malaria in travelers: a review of the GeoSentinel surveillance network.GeoSentinel surveillance of illness in returned travelers, 2007-2011Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network.ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in MiceHuman parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells.Seasonality, annual trends, and characteristics of dengue among ill returned travelers, 1997-2006.Travel-associated illness trends and clusters, 2000-2010.Electronic estimations of renal function are inaccurate in solid-organ transplant recipients and can result in significant underdosing of prophylactic valganciclovir.A comparative analysis of methodological approaches used for estimating risk in travel medicine.Development and validation of an instrument to assess the risk of developing viral infections in Australian travelers during international travel.Enhanced apoptosis in post-liver transplant hepatitis C: effects of virus and immunosuppressantsHepatitis B and C infection in international travelers.Prevention of hepatitis C virus infection and liver cancer.Latitudinal patterns of travel among returned travelers with influenza: results from the GeoSentinel Surveillance Network, 1997-2007.Vaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance Network.The profile of health problems in African immigrants attending an infectious disease unit in Melbourne, Australia.Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa.Gastrointestinal infection among international travelers globally.Preparing for introduction of a dengue vaccine: recommendations from the 1st Dengue v2V Asia-Pacific Meeting.Seroepidemiology of dengue in travellers: a paired sera analysis.Illness in returned travelers and immigrants/refugees: the 6-year experience of two Australian infectious diseases units.Two cases of Old World cutaneous leishmaniasis in Australian travelers visiting Morocco.Dysregulation of hepatocyte cell cycle and cell viability by hepatitis B virus.
P50
Q26862854-883DFFE1-1756-4995-A1A7-EA9D4A575443Q28345952-B3A625E3-4DA3-4CDF-9A85-464CF7523F04Q28548318-876F105A-61C8-4E50-98E1-1BF759854C2AQ30409820-FD882D17-9749-4AA9-BE43-8C71073C4FE9Q30411633-2B75B5D5-81EA-4EE1-BA7D-B5EA0F05F985Q30418215-D1CFBDEE-C368-4C5E-ACA6-C778F2D5A64DQ31918157-AF9C5E45-520E-4C5E-B00C-3CA6E8D0CF7BQ33273910-891EF027-B8EA-4A85-8CD7-C0413793F41DQ33418396-45153033-C671-487B-B355-AF617BA3DDA0Q33428610-646D2FFB-CA72-479A-A297-7C6804F35E86Q33574740-8EF781E1-B3AB-4704-9044-EF783ECD60CEQ34091925-D5058F3A-0FD9-420C-8251-7F36D6806F74Q34159081-728C4EC1-46E5-4F33-9337-5BAA7D357972Q34455275-8C51F0C8-FDD9-4AE9-868F-2F003ADCBA54Q34473175-09B5F3E0-073B-4C27-8B53-E7849C718FE7Q35059755-A5DD5D2C-FD46-4BD4-87D6-4C173F4CCAACQ35590251-02514D7C-6FD9-4263-BFA6-DFA825866740Q35919384-F98C321E-7CA8-4632-BDD1-DEBC354183B7Q36239501-690626E2-C1C9-4B22-A774-81A9F3C886A7Q36618024-61408238-71CC-4DDF-BEC8-3E9F5F156219Q36757066-9D0C1BDA-00A0-40D2-B7B3-A084FC990E6CQ36845694-893EEC31-3820-427C-A4D1-08B1175BA9DAQ37009420-644A8F6A-6159-4654-868C-E26905A8F9FFQ37021081-A6CFD534-18EA-406F-8558-52FA8D13F311Q37036531-869849DB-AE6A-41B8-93C5-F171ADC4333DQ37230471-139F9863-110D-4561-B588-B4B15E9D7F40Q37896697-F9DE3A56-92D6-4C53-B16E-916AD46F69E8Q38011694-86E85975-76F7-4A35-B7D7-C854064FCE08Q38098235-57E18CFD-98E4-4922-90AC-07B23CA879B4Q38134547-3142B81D-6274-4AA5-8262-70FEC1AEB991Q38913228-4757759F-215A-4359-A1E7-B957F0BF230DQ38913240-3383FD6D-1E3F-4CFE-837E-391F1B87DA39Q39023073-9CB287A7-3D81-4F58-B18B-1230E9BBEFD5Q39023078-00D56EBA-72EF-4A3B-9277-E8C2C7462B3DQ39032840-BE09D89C-EDF3-4B59-AF80-CBA9B707737FQ39158144-81C03915-3553-4D27-AFB4-5DCC61702CB1Q39165749-A4E41484-D3B0-4D8D-86DC-86BCC4D01AEBQ39313787-574A8E59-8F66-45F1-A0DC-67E784ED1C05Q39490686-B94595B7-A371-4439-91C2-0CBB1668A68AQ39794252-E50BC871-9164-48B3-BB5E-8B6D525C390F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joseph Torresi
@ast
Joseph Torresi
@en
Joseph Torresi
@es
Joseph Torresi
@nl
Joseph Torresi
@sl
type
label
Joseph Torresi
@ast
Joseph Torresi
@en
Joseph Torresi
@es
Joseph Torresi
@nl
Joseph Torresi
@sl
prefLabel
Joseph Torresi
@ast
Joseph Torresi
@en
Joseph Torresi
@es
Joseph Torresi
@nl
Joseph Torresi
@sl
P106
P21
P31
P496
0000-0002-8212-0887